SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-008116
Filing Date
2001-03-26
Accepted
2001-03-26 00:00:00
Documents
9
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2042395z10-k.txt 10-K 287670
2 EXHIBIT 3.4 a2042395zex-3_4.txt EX-3.4 39056
3 EXHIBIT 10.4 a2042395zex-10_4.txt EX-10.4 42100
4 EXHIBIT 10.9 a2042395zex-10_9.txt EX-10.9 40985
5 EXHIBIT 10.10 a2042395zex-10_10.txt EX-10.10 8853
6 EXHIBIT 10.14 a2042395zex-10_14.txt EX-10.14 25153
7 EXHIBIT 10.16 a2042395zex-10_16.txt EX-10.16 297165
8 EXHIBIT 10.26 a2042395zex-10_26.txt EX-10.26 242447
9 EXHIBIT 23 a2042395zex-23.txt EX-23 636
  Complete submission text file 0000912057-01-008116.txt   986366
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 1578421
SIC: 2834 Pharmaceutical Preparations